Global Forum of Cancer Surgeons: Perspectives on Barriers to Surgical Care for Cancer Patients and Potential Solutions Chandrakanth AreKelly M. McMastersMasaki Mori Health Services Research and Global Oncology 25 March 2019 Pages: 1577 - 1582
Thirty Years of Counting Cancer Cases: The Collective Effort and Efficacy of the National Cancer Database Cary Jo R. SchlickDavid J. Bentrem Health Services Research and Global Oncology 06 March 2019 Pages: 1583 - 1584
The Value of Commission on Cancer Accreditation: Improving Survival Outcomes by Enhancing Compliance with Quality Measures Subhasis MisraJi FanChandrakanth Are Colorectal Cancer 29 March 2019 Pages: 1585 - 1587
Does Sidedness Matter in Unresectable Colorectal Cancer? Suneel D. KamathAlok A. Khorana Colorectal Cancer 18 March 2019 Pages: 1588 - 1591
Minimally Invasive Lymphadenectomy for Biliary Tumors: Stepwise Progress Jason W. DenboSchelomo MarmourEric H. Jensen Hepatobiliary Tumors 27 March 2019 Pages: 1592 - 1593
Living Donor Liver Transplant for Hepatocellular Carcinoma Vijay SubramanianWilliam Chapman Hepatobiliary Tumors 01 April 2019 Pages: 1594 - 1595
Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When? Michael P. KimMatthew H. G. Katz Pancreatic Tumors 24 January 2019 Pages: 1596 - 1597
Staging for Ampullary Carcinoma: Is Less Actually More? Jordan M. Cloyd Pancreatic Tumors 20 February 2019 Pages: 1598 - 1600
Raining Frogs, Flying Horses, and Defining Tumor Rupture in GIST E. A. AsareB. W. Feig Sarcoma 22 March 2019 Pages: 1601 - 1603
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012–2014 Katherine MallinAmanda BrownerHeidi Nelson Health Services Research and Global Oncology 08 February 2019 Pages: 1604 - 1612
Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer’s Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections Lawrence N. ShulmanAmanda E. BrownerDaniel P. McKellar Health Services Research and Global Oncology 29 March 2019 Pages: 1613 - 1621
Survey of Surgical Oncology Fellowship Graduates 2005–2016: Insight into Initial Practice Samantha RuffSadia IlyasJeremy L. Davis Health Services Research and Global Oncology 13 February 2019 Pages: 1622 - 1628
Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery Yuichi NagakawaYatsuka SaharaAkihiko Tsuchida Pancreatic Tumors 04 January 2019 Pages: 1629 - 1636
ASO Author Reflections: Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer: Is Combined Radiotherapy Necessary? Yuichi Nagakawa ASO Author Reflections 19 February 2019 Pages: 1637 - 1638
The Prognostic Relevance of the New 8th Edition of the Union for International Cancer Control Classification of TNM Staging for Ampulla of Vater Carcinoma Taisuke ImamuraYusuke YamamotoKatsuhiko Uesaka Pancreatic Tumors 21 February 2019 Pages: 1639 - 1648
Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic Review Qiuyi HuangHaiyang ZhouXianjun Yu Pancreatic Tumors 28 March 2019 Pages: 1649 - 1656
Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer Dimitrios MorisNikolaos MachairasTimothy M. Pawlik Hepatobiliary Tumors 06 March 2019 Pages: 1657 - 1668
Defining Tumor Rupture in Gastrointestinal Stromal Tumor Toshirou NishidaToto HølmebakkPiotr Rutkowski Sarcoma Open access 13 March 2019 Pages: 1669 - 1675
Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Xuezhi ZhouYongju YiJie Tian Colorectal Cancer Open access 18 March 2019 Pages: 1676 - 1684
Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I–III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis Shu-Huan HuangWen-Sy TsaiJinn-Shiun Chen Colorectal Cancer 26 March 2019 Pages: 1685 - 1694
Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance Gillian KuehnerJeanne DarbinianLou Fehrenbacher Breast Oncology 08 February 2019 Pages: 1695 - 1703
Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands Annnelotte van BommelPauline SpronkThijs van Dalen Breast Oncology Open access 04 March 2019 Pages: 1704 - 1711
Effects of Antihypertensive Drugs on Outcomes of Breast Reconstruction Jin-Woo ParkKyeong-Tae LeeGoo-Hyun Mun Breast Oncology 12 March 2019 Pages: 1712 - 1719
Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery Ko Un ParkHenry M. KuererDalliah M. Black Breast Oncology 14 March 2019 Pages: 1720 - 1728
The Relationship of Breast Density and Positive Lumpectomy Margins Jessica C. GoochEsther YoonFreya Schnabel Breast Oncology 19 March 2019 Pages: 1729 - 1736
Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up Amblessed E. OnumaEliza W. BealLawrence A. Shirley Endocrine Tumors 28 February 2019 Pages: 1737 - 1743
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma Misaki IijimaTakehiko YokoboriHiroyuki Kuwano Endocrine Tumors 28 March 2019 Pages: 1744 - 1750
Thyroid Antibody Status is Associated with Central Lymph Node Metastases in Papillary Thyroid Carcinoma Patients with Hashimoto’s Thyroiditis Xingzhu WenBin WangMing Qiu Endocrine Tumors 01 April 2019 Pages: 1751 - 1758
Does Noncompliance in Lymph Node Dissection Affect Oncological Efficacy in Gastric Cancer Patients Undergoing Radical Gastrectomy? Qi-Yue ChenQing ZhongChang-Ming Huang Gastrointestinal Oncology 12 February 2019 Pages: 1759 - 1771
The Relevance of Serosal Exposure Without Nodal Metastasis in Resectional Gastric Cancer Yoon Ju JungHo Seok SeoHan Hong Lee Gastrointestinal Oncology 14 February 2019 Pages: 1772 - 1778
A Phase 2 Study of Induction Chemotherapy Using Docetaxel, Cisplatin, and S-1 for Gastric Cancer with Peritoneal Metastasis (KUGC06) Hiroshi OkabeHiroaki HataThe Kyoto University Surgical Oncology Group (KUSOG) Gastrointestinal Oncology 14 February 2019 Pages: 1779 - 1786
Diagnostic Accuracy and Usefulness of Intraoperative Margin Assessment by Frozen Section in Gastric Cancer Koki NakanishiShinji MoritaHitoshi Katai Gastrointestinal Oncology 14 March 2019 Pages: 1787 - 1794
Can We Accurately Identify Peritoneal Metastases Based on Their Appearance? An Assessment of the Current Practice of Intraoperative Gastrointestinal Cancer Staging Thomas SchnelldorferMatthew P. WareRobin Ruthazer Gastrointestinal Oncology 25 March 2019 Pages: 1795 - 1804
Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis Masayuki KanoKoichi HayanoHisahiro Matsubara Gastrointestinal Oncology Open access 11 April 2019 Pages: 1805 - 1813
Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium Alexandra G. Lopez-AguiarCecilia G. EthunShishir K. Maithel Hepatobiliary Tumors 15 March 2019 Pages: 1814 - 1823
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer Raja R. NarayanDebra A. GoldmanT. Peter Kingham Hepatobiliary Tumors 31 January 2019 Pages: 1824 - 1832
Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation Vlasios S. SotirchosSho FujisawaConstantinos T. Sofocleous Hepatobiliary Tumors 04 March 2019 Pages: 1833 - 1840
Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma Anfeng SiJun LiFeng Shen Hepatobiliary Tumors 06 March 2019 Pages: 1841 - 1850
Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal Staging Sean P. MartinJustin DrakeJonathan M. Hernandez Hepatobiliary Tumors 20 March 2019 Pages: 1851 - 1857
Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension Satoshi OgisoSatoru SeoShinji Uemoto Hepatobiliary Tumors 18 March 2019 Pages: 1858 - 1858
Liver Resection with In Situ Hypothermic Perfusion: An Old but Effective Method Karl J. OldhaferGregor A. StavrouMohammad H. Fard-Aghaie Hepatobiliary Tumors Open access 24 February 2019 Pages: 1859 - 1859
False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma Amanda A. G. NijhuisMbathio DiengRachael L. Morton Melanoma 25 March 2019 Pages: 1860 - 1868
Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma Yoichi HamaiJun HiharaMorihito Okada Thoracic Oncology 23 January 2019 Pages: 1869 - 1878
The Role of Adjuvant Radiotherapy in the Treatment of Pleural Mesothelioma Gary D. LewisShraddha M. DalwadiBin S. Teh Thoracic Oncology 24 February 2019 Pages: 1879 - 1885
Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study Xintong WangXiaomeng LiuBaosheng Li Thoracic Oncology 25 February 2019 Pages: 1886 - 1892
Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer Naoya YoshidaYohei NagaiHideo Baba Thoracic Oncology 12 March 2019 Pages: 1893 - 1900
Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients Yijiu RenHuikang XieChang Chen Thoracic Oncology 18 March 2019 Pages: 1901 - 1908
Tumor Volume Index as a Prognostic Factor in Patients after Curative Esophageal Cancer Resection Hiroshi MiyamotoChikara KunisakiItaru Endo Thoracic Oncology 19 March 2019 Pages: 1909 - 1915
Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients Shinkichi TakamoriKazuki TakadaYoshihiko Maehara Translational Research and Biomarkers 27 February 2019 Pages: 1916 - 1924
A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma Taichi MatsubaraKazuki TakadaYoshihiko Maehara Translational Research and Biomarkers 27 February 2019 Pages: 1925 - 1933